Digital video ad spending is booming, and will continue to grow, as evidenced by last week’s digital Newfronts. As New York Times reports: “Television networks, which rely on the upfront season for tens of billions of ad dollars, are facing declining ratings and heightened competition from digital outlets. And while television still dominates the ad market, with some $70 billion in ad spending last year in the United States, online ad spending is swelling. In particular, digital video, which attracted $5.8 billion in ad spending in the United States last year, is expected to grow to $7.8 billion this year and to $12.8 billion by 2018, according to the research firm eMarketer.” Thanks to Supervisor, Insights & Analytics, Oxana Ahern for this story.
You know I love me a good roundtable. All I learned from PharmExec’s roundtable on rare diseases wouldn’t fit in one paragraph, but some of the top points:
- Pay attention to how rare disease treatments are launched and marketed, because that’s how personalized medicine will look in the future
- Patient advocacy is a great and distinguishing force
- Payers need to be on board – and patients and patient groups can help with that
- “Gene therapy holds significant promise, largely because it will serve as a pathway to cures, not just in our space but in other areas of medicine as well.” –Panelist Philip Ruff, Global Value Strategy Lead, Shire
This chart is fascinating – it shows the changing dietary habits of Americans over the past 40 years. Canned asparagus? No thanks. Fresh mangoes? Oh yeah. Thanks to Chief Operations Officer Jim Woodland, who loves to eat, for this story.
Congratulations to the many pharma companies and CMI/Compas partners included in this “most meaningful companies in America” listing. Thanks to Associate Media Director Melissa Wackes for finding this story.
– Carly Kuper, VP, Strategic Marketing & Corporate Communications
Click here to get The Scoop sent to your inbox daily!